期刊文献+

乳腺癌发生和转移相关差异基因GEO芯片分析 被引量:2

Analysis of differential genes for the occurrence and metastasis of breast cancer based on GEO microarray
原文传递
导出
摘要 目的乳腺癌是威胁女性健康的重大疾病,其发病率日益升高。本研究旨在筛选并验证与乳腺癌发生和转移相关的共同差异基因,并对差异基因进行生物信息学分析,对进一步筛选得出的差异基因进行表达水平验证。方法从基因表达综合(Gene Expression Omnibus,GEO)数据库中下载组织芯片数据GSE109169和GSE100534,用R语言软件筛选差异基因。运用Cytoscape3.6.0进行富集,筛选关键基因,运用STRING数据库对筛选出的共同差异基因进行蛋白互作网络分析,运用Kaplan-Meier Plotter绘制关键基因的生存曲线,运用实时荧光定量聚合酶链反应法(quantitative real-time polymerase chain reaction,qRT-PCR)验证关键基因的mRNA表达水平。结果筛选得到95个可能同时参与乳腺癌发生和转移过程的共同差异基因。共同差异基因主要富集于PI3K信号通路、p53通路、Jak-STAT信号通路、细胞-基质间黏附、细胞分化和胶原代谢过程等。关键蛋白互作网络由13个基因组成,将这13个基因与基因本体论(Gene Ontology,GO)和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)数据库分析得出的共同差异基因取交集,得到3个关键差异基因CDC6、ECT2和RRM2。生存分析表明,高表达这3个基因的患者预后差,总生存率低。qRT-PCR检测结果显示,与正常乳腺上皮细胞相比,这3个关键差异基因在乳腺癌细胞系中的表达升高,差异有统计学意义,P<0.05。结论 CDC6、ECT2和RRM2基因在乳腺癌中的表达高于其在正常乳腺上皮细胞中的表达,与乳腺癌者的预后密切相关。 OBJECTIVE Breast cancer,with the increasing mortality nowadays,is a major disease threatening women’s health.In present study,we aimed to screen and verify the co-differentially expressed genes(co-DEGs)relating to the pathogenesis and metastasis of breast cancer.METHODS Two different gene expression profiles GSE109169 and GSE100534 were obtained from Gene Expression Omnibus(GEO).Co-DEGs were analyzed by R project and enriched by Cytoscape3.6.0.The protein-protein interaction network was constructed by STRING.The survival curves of key DEGs were performed through Kaplan-Meier Plotter and their mRNA levels were tested by qRT-PCR.RESULTS Ninety-five co-DEGs genes with potential impact on the pathogenesis and metastasis of breast cancer were selected.They mainly enriched in PI3 K-Akt signaling pathway,p53 signaling pathway,Jak-STAT signaling pathway,cell-substrate adhesion,cell division and collagen metabolism.The main protein-protein interaction network were made up of 13 genes.Intersection elements of these 13 genes and the co-DEGs,CDC6,ECT2 and RRM2 was selected as key genes that may have specific effects on the pathogenesis and metastasis of breast cancer.Kaplan-Meier survival curve analysis revealed that high expression of CDC6,ECT2 and RRM2 resulted in a significant decrease in overall survival.Quantitative RT-PCR results revealed that CDC6,ECT2 and RRM2 were high expressed in breast cancer cells compared to normal breast epithelial cells(P<0.05).CONCLUSION The highly expressed genes,CDC6,ECT2 and RRM2,in breast cancer cells,may closely relate to the prognosis of breast cancer patients.
作者 全东令 陈凯 管怡晴 张静茹 杨丹妮 吴焕贤 张国华 吕琳 QUAN Dong-ling;CHEN Kai;GUAN Yi-qing;ZHANG Jing-ru;YANG Dan-ni;WU Huan-xian;ZHANG Guo-hua;LYU Lin(Southern Medical University,Guangzhou 510515,P.R.China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2020年第1期27-34,46,共9页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81473246)
关键词 生物信息学 乳腺癌 增殖和转移 细胞分裂周期蛋白6 核糖核苷酸小亚基M2 上皮细胞转化序列2 bioinformatics breast cancer occurrence and metastasis cell division cycle 6 ribonucleotide reductase epithelial cell transforming sequence 2
  • 相关文献

参考文献4

二级参考文献42

  • 1郑金锋,马淑芳,耿明,曹永成,刘莹.p16和p15及PCNA在子宫颈癌组织中的表达及临床病理意义[J].中华肿瘤防治杂志,2007,14(4):291-293. 被引量:15
  • 2Diaz-montes TP, Bristow RE. Secondary cytoreduction for pa- tients with recurrent ovarian cancer [J]. Curr Oncol Rep, 2005,7 (6) :451-458.
  • 3Grade M, Hummon AB, Camps J, et al. A genomic strategy for the functional validation of colorectal cancer genes identifies po- tential therapeutic targets[J]. Int J Cancer, 2011,128(5) : 1069- 1079.
  • 4Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method[J]. Methods,2001,25(4) :402-408.
  • 5Bookman MA. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinie[J]. Int J Gynecol Cancer, 2005,15(Suppl I) : 12-17.
  • 6Smith BD,Karp JE. Ribonucleotide reductase: an old target with new potential[J]. Leuk Res,2003,27(12) : 1075-1076.
  • 7Duxbury MS, Ito H, Benoit E, et al. Retrovirlly mediated RNA interference targeting the M2 subunit of ribonueleotide reduc- tase:a novel therapeutic strategy in pancreatic cancer[J]. Surger- y, 2004,136 (2) : 261-269.
  • 8Burton TR, Kashour T, WrJight J A, et al. Cellular signaling pathways affect the function of ribonuleotie reductase mRNA binding proteins: mRNAs tabilization,drug resistance,and malignancy (Review) [J]. Int J Oncoi,2003,22(1) :21-31.
  • 9Xu X, Page JL, Suttees JA, et al. Broad overexpression of ribonue- leotide reductase genes in mice specifically induces lung neoplasms [J]. Cancer Res,2008,68(8) :2652-2660.
  • 10Wang X, Zhenchuk A, Wiman KG, et al. Regulation of p53 R2 and its role as potential target for cancer therapy [J]. Cancer Lett,2009,276(1) : 1-7.

共引文献25

同被引文献29

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部